In vivo Safety and Antitumor Efficacy of Bifunctional Small Hairpin RNAs Specific for the Human Stathmin 1 Oncoprotein

Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells

(2010) T-Y Jeon et al.   BRITISH JOURNAL OF CANCER

Silencing of focal adhesion kinase by tumor direct injection of small interfering RNA decreases in vivo tumor growth

(2010) Kae Tsutsumi et al.   CANCER BIOLOGY & THERAPY

Stathmin/oncoprotein 18, a microtubule regulatory protein, is required for survival of both normal and cancer cell lines lacking the tumor suppressor, p53

(2010) Bruce K. Carney et al.   CANCER BIOLOGY & THERAPY

Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference

(2010) D D Rao et al.   CANCER GENE THERAPY

A combinatorial approach for targeted delivery using small molecules and reversible masking to bypass nonspecific uptake in vivo

(2010) Q Shi et al.   GENE THERAPY

Hereditary inclusion body myopathy: single patient response to GNE gene Lipoplex therapy

(2010) Gregory Nemunaitis et al.   JOURNAL OF GENE MEDICINE

Genome remodelling in a basal-like breast cancer metastasis and xenograft

(2010) Li Ding et al.   NATURE

Small-cell neuroendocrine carcinoma of the prostate: are heterotransplants a better experimental model?

(2009) Lluis-A. Lopez-Barcons   ASIAN JOURNAL OF ANDROLOGY

Tumor-directed gene therapy in mice using a composite nonviral gene delivery system consisting of the piggyBac transposon and polyethylenimine

(2009) Yu Kang et al.   BMC CANCER

Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development

(2009) D D Rao et al.   CANCER GENE THERAPY

Systemic Therapeutic Gene Delivery for Cancer: Crafting Paris Arrow

(2009) Alex Tong et al.   CURRENT GENE THERAPY

Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatment

(2009) Marc T Abrams et al.   MOLECULAR THERAPY

PDX-1 Acts as a Potential Molecular Target for Treatment of Human Pancreatic Cancer

(2009) Shihe Liu et al.   PANCREAS

Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis

(2009) Y.-H. Huang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Recent advances in p53 research: an interdisciplinary perspective

(2008) M Olivier et al.   CANCER GENE THERAPY

Down-regulation of stathmin is required for TGF-β inducible early gene 1 induced growth inhibition of pancreatic cancer cells

(2008) Lei Jiang et al.   CANCER LETTERS

Importance of Translation and Nonnucleolytic Ago Proteins for On-Target RNA Interference

(2008) Ligang Wu et al.   CURRENT BIOLOGY

Antisense, RNAi, and gene silencing strategies for therapy: Mission possible or impossible?

(2008) E RAYBURN et al.   DRUG DISCOVERY TODAY

Stathmin 1: a novel therapeutic target for anticancer activity

(2008) Shushan Rana et al.   Expert Review of Anticancer Therapy

Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation

(2008) John P. Sinek et al.   JOURNAL OF MATHEMATICAL BIOLOGY

Stathmin Activity Influences Sarcoma Cell Shape, Motility, and Metastatic Potential

(2008) Barbara Belletti et al.   MOLECULAR BIOLOGY OF THE CELL

Nonviral Delivery for Genomic Therapy of Cancer

(2008) Nancy Smyth Templeton   WORLD JOURNAL OF SURGERY